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ASTRACT 
The optimal way to manage diabetic foot osteomyelitis remains uncertain, with 
debate in the literature as to whether it should be managed conservatively (i.e. non-
surgically) or surgically. We aimed to identify clinical variables that influence 
outcomes of non-surgical management in diabetic foot osteomyelitis. We conducted 
a retrospective study of consecutive patients with diabetes presenting to a tertiary 
centre between 2007 and 2011 with foot osteomyelitis initially treated with non-
surgical management. Remission was defined as wound healing with no clinical or 
radiological signs of osteomyelitis at the initial or contiguous sites 12 months after 
clinical and or radiological resolution. Nine demographic and clinical variables 
including osteomyelitis site and presence of foot pulses were analysed. We identified 
100 cases, of which 85 fulfilled the criteria for analysis. After a 12 month follow up 
period, 54 (63.5%) had achieved remission with non-surgical management alone 
with a median (IQR) duration of antibiotic treatment of 10.8 (10.1) weeks. Of these, 
14 (26%) were admitted for intravenous antibiotics. The absence of pedal pulses in 
the affected foot (n = 34) was associated with a significantly longer duration of 
antibiotic therapy to achieve remission, 8.7 (7.1) vs 15.9 (13.3) weeks (P=0.003). 
Osteomyelitis affecting the metatarsal was more likely to be amputated than other 
sites of the foot (P=0.016). In line with previous data, we have shown that almost two 
thirds of patients presenting with osteomyelitis healed without undergoing surgical 
bone resection. The absence of foot pulses on the affected side was associated with 
requiring a significantly longer duration of antibiotic therapy. Furthermore, 
osteomyelitis of the metatarsal was significantly more likely to undergo amputation 
than other sites in the foot.  
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 Abbreviations  
DFO  Diabetic foot osteomyelitis 
MRSA  Meticillin-resistant Staphlococcus aureus 
eGFR  estimated Glomerular Filtration Rate 
 
INTRODUCTION 
Diabetic foot ulceration is one of the most common ‘diabetes specific’ complications 
resulting in hospital admission.1 There are an estimated 6,000 diabetes related 
amputations per year in England alone with the cost of diabetes related foot disease, 
in particular osteomyelitis and amputation, calculated to be approximately £580 
million per annum.2,3  
It is well recognised that osteomyelitis complicates a significant proportion of diabetic 
foot infections.4,5 However, despite this, the optimal management of diabetic foot 
osteomyelitis (DFO) is controversial, with limited evidence to guide the initial 
treatment strategy.6 Some authors advocate a primarily surgical approach, and 
believe that antibiotic therapy alone may worsen outcomes with decreased wound 
healing and more major amputations.7,8 In addition, where surgery has been 
required, authors have shown that early intervention improves outcomes.9 In 
contrast, several retrospective case series have demonstrated that between 58-80% 
of DFO can be successfully managed with antibiotics alone.10,11,12,13,14,15,16 However 
this still leaves a proportion of patients who receive an extended period of antibiotics 
without benefit before eventually undergoing amputation. The ability to predict from 
the outset those patients likely to require surgical intervention could improve patient 
outcomes and the health economy. To date there is a paucity of data on what factors 
influence outcomes in patients with DFO presenting to outpatient clinics. In a 
retrospective review of 50 patients with conservatively treated DFO, Senneville et al. 
found that only bone culture-based antibiotic therapy was a factor significantly 
predictive of remission. However, bone biopsy is not routinely performed in many 
centres. The objective of this study was to evaluate the influence of several patient 
variables on the outcomes of DFO where the initial approach was non-surgical. 
PATIENTS AND METHODS 
We carried out a retrospective study of consecutive DFO cases presenting to a 
tertiary diabetic foot clinic over a period from July 2008 to December 2011.  
Case selection and definitions 
Cases were identified by searching for “osteomyelitis” and “diabetes” from the 
comprehensive departmental electronic clinic database at our institution. A diagnosis 
of DFO required at least one feature of clinical suspicion; positive probe-to-bone test, 
visible bone at ulcer base, sausage deformity of the toe, and at least one of the 
following supportive radiographic features; periosteal reaction, loss of trabecular 
architecture, endosteal scalloping, bone destruction, or sequestered bone.17,18,19,20 
All patients had plain radiographs taken, and where this was indeterminate, an MRI 
was done. Patients with at least one supportive MRI feature of osteomyelitis 
including periosteal reaction, sequestrum and characteristic alteration in bone 
marrow signal intensity were then included in the study. Inflammatory markers were 
measured at baseline. Bone biopsies were not performed in our institution. The 
HbA1c values were taken within a 3 month period before the diagnosis of DFO was 
made. Treatment was defined as non-surgical if no surgical intervention involving the 
bone had taken place during the treatment episode. For each case identified, a 
search for discharge summaries in the hospital’s electronic patient record system 
(Integrated Clinical Environment (ICE)TM, Sunquest Information Systems (Ltd), 
Norwich UK) was performed to identify patients who were admitted for the treatment 
of osteomyelitis and whether they had intravenous antibiotics or surgery. 
Case management standards 
Patients were managed by a multi-disciplinary team consisting of a vascular 
surgeon, an orthopaedic surgeon, a podiatrist and a diabetologist with a specialist 
interest in diabetic feet. Patients underwent standard management with ulcer 
debridement and pressure off-loading. The potential need for revascularisation was 
considered on a case by case basis. Deep soft tissue samples were taken from the 
wound for culture and sensitivities and antibiotics were given according to local 
antimicrobial guidelines and culture results.21 Soft tissue infection was classified in 
line with Infectious Disease Society of America guidelines as mild, moderate or 
severe depending on the degree of inflammation or cellulitis around the ulcer, 
response to oral antibiotics and signs of systemic toxicity.22 In non-penicillin allergic 
patients with mild infections co-amoxiclav was first choice. For moderate infections 
ciprofloxacin and metronidazole were added in, and those with severe infections 
would be admitted for intravenous piperacillin, and tazobactam with or without 
vancomycin. In our institution, the initial standard of care is antibiotic therapy, with 
regular clinical review in a combined foot clinic comprising concurrent (non-surgical) 
podiatry, medical and surgical (vascular/orthopaedic) input. If there was no evidence 
of healing or deterioration, then a joint consensus on further management was made 
– either changing the antibiotic, or progressing to surgical debridement and/or 
amputation. Specialist microbiological advice was sought as necessary. 
Evaluation of outcomes 
The end of the osteomyelitis episode was defined as wound healing with no clinical 
or radiological signs of infection at the initial or contiguous sites at which point 
treatment with antibiotics was stopped. In those who underwent surgery, the end of 
episode was defined as at the point of discharge following amputation or, if they 
were discharged with antibiotics the point at which antibiotics were stopped. 
Remission was defined as meeting the above criteria 12 months after the end of the 
episode without further surgical intervention, radiological changes or the requirement 
for further antibiotic therapy.   
Statistical analysis 
Comparisons between the groups requiring amputation and those treated non-
surgically were made according to the nature and distribution of the characteristics. 
Distributions were judged by inspection of histograms. For approximately normally 
distributed data the differences in means were calculated and tested using 2 sided t-
tests. For categorical data the number and percentages in each group were 
tabulated and the differences in these percentages tested using the chi-square test 
(or the Fisher’s exact test where expected numbers in any cell of the cross-tabulation 
were less than 5). For categorical characteristics the effect size (measuring the 
contrast between groups) was calculated as the Odds Ratio (OR) for amputation vs. 
not, comparing the index characteristic with the alternative. In the case of ulcer site 
with several categories the odds for amputation were compared for each site with 
those for metatarsal head (arbitrary reference category). A logistic regression 
analysis was performed to evaluate factors that may predict amputation. 
  
An analysis of the length of the antibiotic treatment period (in days) was done using 
medians and inter-quartile range (IQR) to describe sub-groups defined by whether or 
not the patient had at least one pedal pulse at diagnosis.  This was done separately 
for those whose episode ended in amputation or not. The continuity-corrected 
median test was used to test the differences between the median episode lengths 
between pulse- and no-pulse groups. All variables were stratified according to the 
outcome of success or failure of non-surgical management. Failure was defined as 
requiring amputation. Comparison of continuous variables was performed using a 
two-tailed t test and categorical variables such as organism cultured by Fisher’s 
exact test. The P-value for comparison between pulses present or absent was 
derived from the continuity-corrected median test. Statistical significance was 
defined as P < 0.05. Statistical analysis was performed using SPSS software (IBM 
Ltd, Portsmouth, UK). 
 
RESULTS 
Patient and episode characteristics 
One-hundred consecutive cases of DFO were initially identified. By the end of the 1 
year follow up period, 12 patients (with 15 episodes of osteomyelitis) had died and 
were excluded from the analysis. Causes of death were ascertained for each patient. 
One patient died from sepsis, 3 from pneumonia, 6 from cardiovascular disease, 1 
from cancer, and 1 from chronic renal failure. The outcomes are shown in Figure 1. 
Descriptive data on patients and osteomyelitis episodes are given in Table 1 
according to whether the episode ended in amputation or not. 
Patient outcomes 
After a 12 month follow up period, remission was achieved in 54 (63.5%) of patients 
with non-surgical management. Of these, fourteen (25.9%) were admitted for 
intravenous antibiotics and 4 (7.4%) required percutaneous revascularisation (two 
underwent popliteal angioplasty, one bilateral femoral angioplasty and one unilateral 
femoral angioplasty). Twenty-nine (34.5%) patients had an amputation. Of those 
managed without surgery, 2 (3.6%) experienced relapse at the initial or contiguous 
site, whilst 10 (17.9%) had a further episode of osteomyelitis at a distant site during 
the 12 month follow up period, most being associated with the development of new 
foot ulcers elsewhere. This compared to 4 (13.8%) and 8 (27.6%) respectively for 
those who underwent amputation (Figure 1). The decision to amputate was made 
after discussion between the patient and the multidisciplinary specialist foot team if 
the foot was failing to respond to conservative treatment. 
Of the 85 patients, 84 had deep tissue samples sent for microbiological analysis at 
the time of initial presentation. Sixty samples grew potentially pathogenic organisms.  
The distribution of these is shown in Table 2.The median duration of antibiotic 
treatment given was 10.8 weeks and the distribution is shown in Figure 2. For those 
achieving remission with non-surgical management, the absence of pedal pulses in 
the affected foot was associated with a significantly longer duration of antibiotic 
therapy to achieve remission. Median (IQR) therapy in patients with at least one 
pedal pulse on the affected side was 8.7 (7.1) vs 15.9 (13.3) weeks in those with 
absent pulses (p=0.003).  These data are shown in Table 3.  
 
Factors predicting amputation 
Logistic regression analysis was carried out as an exploratory analysis to see if there 
were any factors that predicted amputation. The only two variables which were 
significantly associated with amputation were ulcer site (with osteomyelitis affecting 
the metatarsal being significantly more likely to be amputated than other sites of the 
foot (p=0.016)) and the absence of pedal pulses. Combining these two factors 
produces a predictive sensitivity of 65% and a specificity of 74% for amputation.  
DISCUSSION 
The present study shows that remission was achieved in 65.9% of DFO treated with 
non-surgical management. To our knowledge this is only the second study to 
examine factors predictive of remission in diabetic foot osteomyelitis and has a larger 
sample size than the previous study. Our data are consistent with previous reports 
suggesting that surgery should not necessarily be considered as first line treatment 
for DFO . Osteomyelitis of the metatarsal head was more likely to be amputated than 
at other sites in the foot. In those with absent pedal pulses on the affected foot, 
successful non-surgical management was associated with a longer duration of 
antibiotic therapy to achieve remission. However this subgroup was not more likely 
to undergo amputation than those with palpable foot pulses.  
Since the data provided is a consecutive series from a single specialist centre, the 
results are unlikely to be significantly affected by selection bias. Comparison 
between remission rates and factors predicting outcome are strengthened by close 
similarities in case definitions and standard management reported in previous 
studies .  
Despite accumulating evidence that a majority of patients achieve remission with 
non-surgical management, there continues to be discord on the optimal initial 
management strategy in DFO. Whilst there are concerns about subjecting patients to 
long-term broad spectrum antimicrobial therapy, in this study all 85 patients 
managed to complete their prescribed courses without significant adverse side 
effects. Two previous studies have advocated an initial surgical approach to DFO 
based on findings that it reduces rates of more extensive bone resection. However 
both of these studies focused on patients hospitalised with osteomyelitis that are 
likely to have more severe and late presenting disease than an unselected cohort 
presenting to outpatient clinic. When surgery is required, early intervention may 
reduce the need for major amputations and limit exposure to prolonged antibiotic 
therapy and its associated risks. In a recent small randomised study of 46 patients 
comparing medical therapy with conservative surgery the healing rates at 12 weeks 
were similar between the two groups.  
Accepting the risks of prolonged antibiotic therapy and that those who will require 
amputation may benefit from an early intervention, it is of interest to consider what 
factors predict failure of conservative management. Here we report that DFO 
affecting the metatarsal is significantly more likely to have an amputation. Combining 
the site of osteomyelitis with the absence of pedal pulses produced a predictive 
sensitivity of 65% and specificity of 74% for amputation. In line with previous work, 
our data shows that variables such as age, HbA1C, and cultured micro-organism 
have no influence on outcomes. Collectively, these data provide some insight in to 
how patient factors may influence this risk of amputation in DFO.  
A recent study has shown that in a small cohort of 40 patients randomised to either 6 
or 12 weeks of antibiotics, remission rates were similar between the 2 groups at 
65%.23 However, we found that there was an association between absent pedal 
pulses on the affected foot and the duration of antibiotic use. The study by Tone et al 
excluded patients with no foot pulses. Despite these authors’ finding, the appropriate 
time to stop antibiotics in DFO is often subjective. One could argue this result may in 
part reflect observer bias in the clinician’s belief that absence of pedal pulses may 
require a longer duration of antibiotics. However this association could be explained 
by poor tissue perfusion causing reduced penetration of the antimicrobial to the site 
of infection and a slowing of tissue repair which results in a prolonged treatment with 
antibiotics to achieve healing in DFO.24,25 In addition this group were not significantly 
more likely to undergo amputation. This is of particular interest as previous similar 
studies have excluded this patient group from their analysis. Therefore we would 
expect slower progress in this group of patients and prolonged conservative 
management should be tried before considering amputation. Particularly since 
following amputation the wound site is less likely to heal unless vascular insufficiency 
is addressed. It may well be that the differences seen in our study are due to the 
collective input of the MDT who all see the patients in the same room at the same 
time to aid decision making. 
We had a small number of deaths during the study, however, the numbers were 
small, and the proportion of deaths in each arm was similar, 13.6% in the non- 
amputation arm, and 9% in the amputation arm. Causes of death were similar to 
those previously reported.26 
The main limitations to our data are that it is a retrospective cohort study. A 
randomised controlled clinical trial would be the gold standard in comparing 
outcomes of primary medical versus surgical management in DFO. However, even 
though such a study was recently reported, it was limited by a small sample size and 
a larger sample size is required to better evaluate each approach. Such a study is 
likely to prove difficult as it would require randomising patients to surgery that may 
not be required and recruitment could be undermined by patient preferences to avoid 
surgery. Further work utilising increasingly sophisticated and accessible radiological 
techniques in addition to clinical characteristics may provide more contextual 
information to help decide on the optimal initial management of DFO.27,28 In addition, 
this was a single centre study, and whilst we believe this is one of the largest series 
reported, with the longest follow-up, the relatively small sample size make it harder 
to generalise. Another limitation is that in common with previous work, this study is 
limited by difficulties in case definition in the absence of universally accepted criteria 
for osteomyelitis. However the diagnostic methods in the study, including sausage 
deformity and probe to bone test in the presence of characteristic X-ray or MRI 
appearances are used consistently within the literature.29 Furthermore, these are the 
clinical grounds for diagnosis in much of routine practice which strengthens the 
external validity of our results. Recent work - albeit of only modest quality - has 
suggested that extra-corporeal shock wave therapy can be of benefit when treating 
diabetes related foot ulcers, but to date there are very few data using this modality in 
treating osteomyelitis.30 Our centre does not routinely use this technique, and further 
work would need to be done to assess its utility. 
In summary, we have shown that the absence of foot pulses on the affected side in 
DFO is associated with requiring significantly longer duration of antibiotics to induce 
remission. DFO of the metatarsal is significantly more likely to undergo amputation 
than other sites in the foot.  
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Figure 1 
Flow diagram illustrating outcomes of all 100 patients diagnosed with osteomyelitis 
 
Figure 2 
The median duration of antibiotic therapy 
 
Table 1 
Characteristics of osteomyelitis cases, and comparison between those whose 
antibiotic treatment ended with amputation or not. Data are n (%) unless otherwise 
indicated 
 
Table 2 
Distribution of pathogens cultured from deep tissue swabs from 84 patients with 
diabetic foot osteomyelitis 
 
Table 3 
Length of the antibiotic treatment period in those with and without palpable foot 
pulses stratified according to the outcome of amputation or not. 
 
 
Figure 1 
 Total n = 100 
Amputation n = 34 
Died 
n = 3 
Died 
n = 9 
No amputation n = 66 
Hospitalisation for IV antibiotics  
n = 14  
IR, interventional radiology; IV, intravenous 
 
Recurrence 
n = 4 
Remission  
n = 25 
Outpatient with oral antibiotics 
n = 38 
Recurrence 
n = 2 
Remission  
n = 54 
Healed  
n = 56 
Healed  
n = 29 
Angioplasty by IR 
n = 4 
Table 1.  
Characteristic Not amputated Amputated  All Effect size (95%CI)3  P-value 
N 56 (65.9%) 29 (34.5%)  85 (100) -- -- 
Age (years) (mean, SD) 69.6 (12.4) 64.4 (12.4)  67.8 (12.5) 5.17 (-0.46; 10.80)4 0.071 
HbA1c (mmol/l and %) (mean, SD) 62.6 / 7.9 (15.2) 63.5 / 9  (13.2)  62.9 (14.52) -0.7 (-7.5; 6.06)4 0.841 
eGFR <29 mL/min/1.73m2 6 (10.7) 0   6 (7.1) N/A 0.07 
Pedal pulse detected in at least one foot 31 (55.4) 20 (69.0)  51 (60.0) 1.79 (0.69; 4.61 ) 0.23 
Location on foot:- 
 Metatarsal head 
 Proximal phalanx 
 Distal phalanx 
 Heel 
 Mid phalanx 
 
8 (14.3) 
10 (17.9) 
26 (46.4) 
3 (5.4) 
9 (16.1)  
 
13 (44.8) 
7 (24.1) 
7 (24.1) 
0 
2 (6.9) 
  
21 (25.0) 
17 (20.2) 
33 (39.3) 
3 (3.6) 
11 (12.9) 
 
-- (ref.cat) 
0.43 (0.12; 1.59) 
0.17 (0.05; 0.56) 
N/A 
0.14 (0.02; 0.8) 
0.012 
 
 
Previous ulcer at this site 11 (19.6) 7 (24.1)  18 (21.2) 1.30 (0.44;3.82) 0.63 
Previous osteomyelitis  21 (37.5) 13 (44.8)  34 (40.0) 1.35 (0.54; 3.36) 0.52 
Previous amputation 12 (21.4) 9 (31.0)  21 (24.7) 1.65 (0.60; 4.54) 0.33 
Culture result5 37 (67.3) 23 (79.3)  60 (71.4) 1.86 (0.65; 5.39 ) 0.24 
Streptococci 5 (9.1) 3 (10.3)  8 (9.5) 1.15 (0.26; 5.21)  0.852 
Staphylococcus aureus 23 (41.8) 12 (41.4)  35 (41.7) 0.98 (0.39; 2.46) 0.97 
Meticillin Resistant S.aureus 1 (1.8)  2 (6.9)  3 (3.6) 4.0 (0.35; 46.1) 0.272 
Coliforms 11 (20.0) 5 (17.2)  16 (19.1) 0.83 (0.26; 2.7) 0.76 
Pseudomonas aeruginosa 7 (12.7) 1 (3.5)  8 (9.5) 0.25 (0.03; 2.10) 0.252  
1 – P-value from t-test      2– P-value from Fisher’s exact test 
3 – Unless otherwise specified Effect size is Odds Ratio (OR) for amputation vs. not, comparing the index characteristic with the 
alternative. In the case of ulcer site the odds for amputation are compared for each site with those for metatarsal head.  
4 – Effect size is difference in means (not-amputated episodes minus amputated episodes) 
5 – Culture result from deep tissue swab
 Table 2 
Pathogens n 
MSSA  35 (41.7) 
MRSA 3 (3.6) 
MSCoNS 1 (1.2) 
Streptococci 8 (9.5) 
Enterococci 5 (5.9) 
Coliforms 16 (19.1) 
Pseudomonas aeruginosa 8 (9.5) 
Other 3 (3.6) 
Polymicrobial 26 (30.6) 
 
Data are n (%). MSSA, methicillin-susceptible S. aureus; MRSA, methicillin-resistant 
S. aureus, MSCoNS, methicillin-susceptible coagulase-negative staphylococci. 
 
 
  
Table 3 
 
Episode ended 
by amputation 
Length of episode (antibiotic treatment) 
median (IQR) 
 
P-value1 
 No pulse 
present 
At least one pedal 
pulse present 
 
No  15.9 (13.3) 8.7 (7.1) 0.003 
Yes  7.1 (4.1) 8.3 (7.2) 0.901 
  
Pulses were assessed on the affected foot only.  
1 P-value for comparison between pulse present and pulse not present – from 
continuity-corrected median test 
 
 
